Cysteamine Bitartrate

Known as: Tartrate, Cysteamine, Cysteamine Bitartrate [Chemical/Ingredient], Cysteamine Tartrate (1:1) 
An aminothiol salt used in the treatment of nephropathic cystinosis. Cysteamine bitartrate enters the cell and reacts with cystine producing cysteine… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2018
01220102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
INTRODUCTION Cystinosis is a rare, metabolic, autosomal recessive, genetic lysosomal storage disorder characterized by an… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2018
2018
We assessed the performance of magnetic resonance imaging (MRI) proton density fat fraction (PDFF) in children to stratify… (More)
Is this relevant?
2016
2016
BACKGROUND & AIMS No treatment for nonalcoholic fatty liver disease (NAFLD) has been approved by regulatory agencies. We… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
OBJECTIVES To determine the long-term effects of delayed-release cysteamine bitartrate (DR-CYS) based on our previous work that… (More)
  • figure 2
  • figure 1
  • table II
  • figure 3
  • table I
Is this relevant?
2013
2013
A twice-daily microsphere formulation of cysteamine bitartrate has been developed for cystinosis and other potential applications… (More)
Is this relevant?
2013
2013
Homozygous mutations in the gene CLN1 typically result in infantile-onset neuronal ceroid lipofuscinosis, a severe progressive… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2012
2012
OBJECTIVES Treatment with cysteamine reduces the rate of progression to end-stage kidney disease in cystinosis. Although food is… (More)
Is this relevant?
2010
2010
Second International Cystinosis Research Symposium Jerry A. Schneider, Corinne Antignac, Elena Levtchenko and Ranjan Dohil… (More)
Is this relevant?